Evidence map›Paper›PMID 31462675›Full record

ArticleNature communications2019

Author Correction: Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm.

Sho Kubota, Kenji Tokunaga, Tomohiro Umezu, Takako Yokomizo-Nakano, Yuqi Sun, Motohiko Oshima, Kar Tong Tan, Henry Yang, Akinori Kanai, Eisaku Iwanaga and 7 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Cells · 2023
    Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 2 countries.

Sho KubotaLaboratory of Transcriptional Regulation in Leukemogenesis, International Research Center for Medical Sciences (IRCMS), Kumamoto University, 2-2-1 Honjo, Chuo Ward, Kumamoto, 860-0811, Japan.ORCID http://orcid.org/0000-0001-6119-1259
Kenji TokunagaDepartment of Hematology, Kumamoto University, 1-1-1 Honjo, Chuo Ward, Kumamoto, 860-8556, Japan.
Tomohiro UmezuDepartment of Hematology, Tokyo Medical University, 6-7-1 Nishi-Shinjuku, Shinjuku, Tokyo, 160-0023, Japan.ORCID http://orcid.org/0000-0002-0123-8921
Takako Yokomizo-NakanoLaboratory of Transcriptional Regulation in Leukemogenesis, International Research Center for Medical Sciences (IRCMS), Kumamoto University, 2-2-1 Honjo, Chuo Ward, Kumamoto, 860-0811, Japan.
Yuqi SunLaboratory of Transcriptional Regulation in Leukemogenesis, International Research Center for Medical Sciences (IRCMS), Kumamoto University, 2-2-1 Honjo, Chuo Ward, Kumamoto, 860-0811, Japan.
Motohiko OshimaDepartment of Cellular and Molecular Medicine, Chiba University, 1-8-1 Inohana, Chuo Ward, Chiba, 260-8670, Japan.
Kar Tong TanCancer Science Institute of Singapore, National University of Singapore, Singapore, 119077, Singapore.
Henry YangCancer Science Institute of Singapore, National University of Singapore, Singapore, 119077, Singapore.
Akinori KanaiDepartment of Molecular Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, 739-0046, Japan.
Eisaku IwanagaDepartment of Hematology, Kumamoto University, 1-1-1 Honjo, Chuo Ward, Kumamoto, 860-8556, Japan.
Norio AsouDepartment of Hematology, International Medical Center, Saitama Medical University, Saitama, 350-1298, Japan.
Takahiro MaedaDepartment of General Medicine, Nagasaki University, Graduate School of Biomedical Science, Nagasaki, 852-8523, Japan.
Naomi NakagataDivision of Reproductive Engineering, Center for Animal Resources and Development (CARD), Kumamoto University, 2-2-1 Honjo, Chuo Ward, Kumamoto, 860-0811, Japan.
Atsushi IwamaDepartment of Cellular and Molecular Medicine, Chiba University, 1-8-1 Inohana, Chuo Ward, Chiba, 260-8670, Japan.
Kazuma OhyashikiDepartment of Hematology, Tokyo Medical University, 6-7-1 Nishi-Shinjuku, Shinjuku, Tokyo, 160-0023, Japan.
Motomi OsatoCancer Science Institute of Singapore, National University of Singapore, Singapore, 119077, Singapore. csimo@nus.edu.sg.
Goro SashidaLaboratory of Transcriptional Regulation in Leukemogenesis, International Research Center for Medical Sciences (IRCMS), Kumamoto University, 2-2-1 Honjo, Chuo Ward, Kumamoto, 860-0811, Japan. sashidag@kumamoto-u.ac.jp.ORCID http://orcid.org/0000-0003-2318-5987
Kumamoto University · JPNational University of Singapore · SGChiba University · JPTokyo Medical University · JPHiroshima University · JPKumamoto University Hospital · JPNagasaki University · JPSaitama Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID31462675
PMCPMC6713738
OpenAlexW2970664359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.